Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 41, Issue 18, Pages 2624-2637
Publisher
Springer Science and Business Media LLC
Online
2022-03-29
DOI
10.1038/s41388-022-02278-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
- (2020) Andriy Marusyk et al. CANCER CELL
- Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
- (2020) Antonella Sistigu et al. Frontiers in Immunology
- Targeting dormant tumor cells to prevent cancer recurrence
- (2020) Maartje P. F. Damen et al. FEBS Journal
- Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
- (2020) Xiaobin Zeng et al. PHARMACOLOGICAL RESEARCH
- Targeting Cancer Cell Dormancy
- (2019) Ariadna Recasens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Niche-Dependent Myeloid Transcriptome Signature Defines Dormant Myeloma Cells
- (2019) Weng Hua Khoo et al. BLOOD
- Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling
- (2019) Maegan L. Capitano et al. JOURNAL OF CLINICAL INVESTIGATION
- DEK terminates diapause by activation of quiescent cells in the crustacean Artemia
- (2019) Wen-Huan Jia et al. BIOCHEMICAL JOURNAL
- SET domain-containing protein 4 epigenetically controls breast cancer stem cell quiescence
- (2019) Sen Ye et al. CANCER RESEARCH
- Cancer stem cell (CSC) resistance drivers
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Stem cells in cancer initiation and progression
- (2019) Jeevisha Bajaj et al. JOURNAL OF CELL BIOLOGY
- The Complexity of DEK Signaling in Cancer Progression
- (2018) Yong Teng et al. CURRENT CANCER DRUG TARGETS
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival
- (2018) Kari E Hacker et al. NEOPLASIA
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- SETD4 Regulates Cell Quiescence and Catalyzes the Trimethylation of H4K20 during Diapause Formation in Artemia
- (2016) Li Dai et al. MOLECULAR AND CELLULAR BIOLOGY
- DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma
- (2016) Jie Sun et al. ONCOLOGY REPORTS
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- The DEK oncoprotein and its emerging roles in gene regulation
- (2015) C Sandén et al. LEUKEMIA
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- High expression of DEK predicts poor prognosis of gastric adenocarcinoma
- (2014) Junjie Piao et al. Diagnostic Pathology
- The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation
- (2014) Carl Sandén et al. Molecular Cancer
- Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma
- (2014) HUO-CHUN YI et al. Molecular Medicine Reports
- The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers
- (2014) L M Privette Vinnedge et al. ONCOGENE
- The DREAM Complex Mediates GIST Cell Quiescence and Is a Novel Therapeutic Target to Enhance Imatinib-Induced Apoptosis
- (2013) S. Boichuk et al. CANCER RESEARCH
- Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
- (2013) Jason D Buenrostro et al. NATURE METHODS
- Intercellular trafficking of the nuclear oncoprotein DEK
- (2013) A. K. Saha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C/EBP and DEK coordinately regulate myeloid differentiation
- (2012) R. I. Koleva et al. BLOOD
- The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
- (2012) Hua Gao et al. CELL
- DEK overexpression is correlated with the clinical features of breast cancer
- (2012) Shuangping Liu et al. PATHOLOGY INTERNATIONAL
- Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
- (2011) D. Z. Ewton et al. MOLECULAR CANCER THERAPEUTICS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- The human DEK oncogene regulates DNA damage response signaling and repair
- (2011) Gina M. Kavanaugh et al. NUCLEIC ACIDS RESEARCH
- Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML
- (2010) Yoriko Saito et al. NATURE BIOTECHNOLOGY
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene
- (2009) M. S. Khodadoust et al. CANCER RESEARCH
- Progress in studies on the DEK protein and its involvement in cellular apoptosis
- (2009) Ying Hua et al. Science in China. Series C, Life sciences / Chinese Academy of Sciences
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now